Oncology Models | Charles River Discovery Services

Orthotopic Models 

Renal Sub-Capsule Orthotopic Model

The renal orthotopic model was developed for the efficacy evaluation of novel anti-cancer compounds using a model that mimics the disease process in humans. Cell lines utilized in this model include 786-O and Caki-1.

Effect of Drug A and Drug B on Caki-1 Tumor Volume

 

Effect of Drug A and Drug B on Caki-1 Tumor Volume

 


Intracranial Orthotopic Model

Intracranial injection of tumor cells mimics clinical responses to tumor growth. Test agent effects are evaluated based on clinical observations and sample analyses. We have used the U87MG human glioma models successfully in mice.

Effect of TMZ or BCNU on TTE


Effect of TMZ or BCNU on TTE (1x106 U87MG Cells)

 

 

Intrasplenic Hepatic Colonization Model

Orthotopic seeding of human tumor cell lines allows assessment of tumor development in a hepatic environment and provides efficacy evaluation in a preclinical model mimicking the disease process in humans. This allows for a more representative picture of tumor growth and response to therapy scenario to be realized.

Response in the HCT116-e314 Intrasplenic Implant / Liver Growth Study

Orthotopic Breast Tumor Model

Either BT474 or MX-1 cancer lines can be injected directly into the mammary fat pad of the mouse in this orthotopic model.

Systemic Leukemia/Lymphoma Model

In this model, Raji-B, MV4-11 and Ramos tumor cells are injected by IV tail vein. Clinical signs associated with progression of tumor include impairment of hind limb function, ocular proptosis and weight loss.

For more information about our orthotopic cancer models, please contact us at askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

+33 (0)4 74 01 69 69
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.